Here, we found that a higher ACSL1 level exists in senescent K562 cells and increased ACSL1 promotes imatinib-induced chronic myeloid leukemia cell senescence. This evidence concerns the gene ACSL1 and chronic myelogenous leukemia, BCR-ABL1 positive.